ASCM
OGEN icon

Adkins Seale Capital Management’s Oragenics OGEN Stock Holding History

Adkins Seale Capital Management’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
3
– – ﹤0.01% 236
2026
Q1 		$2 Hold
3
– – ﹤0.01% 227
2025
Q4 		$2 Buy
+3
New +$3 ﹤0.01% 226

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Adkins Seale Capital Management's OGEN Position: Q2 2026 in Review

Adkins Seale Capital Management held its Oragenics (OGEN) position steady in Q2 2026 at 3 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #236.

Adkins Seale Capital Management first reported a position in OGEN in Q4 2025 and has held it in 3 quarters since. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • Adkins Seale Capital Management held 3 shares of Oragenics worth $2 as of Q2 2026.
  • Adkins Seale Capital Management left its Oragenics share count unchanged in Q2 2026.
  • Oragenics made up ﹤0.01% of Adkins Seale Capital Management's portfolio in Q2 2026, its #236 holding.
  • Adkins Seale Capital Management first reported a position in Oragenics in Q4 2025 and has held it in 3 quarters since.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Adkins Seale Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.